secwatch.observer — SEC 8-K summary
======================================

Issuer:     Context Therapeutics Inc. (CNTX)
CIK:        0001842952
Form:       8-K
Filed at:   2025-10-24T23:59:59+00:00
Accession:  0001628280-25-046258
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Context Therapeutics amends ATM agreement to increase offering capacity to up to $75M
--------------------------------------------------------------------------------

- Prior ATM: sold 14.7M shares for ~$15M through Dec 2, 2024 to Oct 24, 2025.
- Amendment raises aggregate offering to $75M (excl. prior sales) under new S-3 effective Nov 14, 2024.
- New prospectus supplement dated Oct 24, 2025; agent Leerink commission up to 3% of gross proceeds.
- Proceeds intended for R&D, working capital, and general corporate purposes.
- Prior ATM prospectus terminated; no further sales under that facility.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1842952/000162828025046258/0001628280-25-046258-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1842952/000162828025046258/cntx-20251024.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-046258

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer